Maharashtra reports 8 Covid-19 cases, 5 from Mumbai
No death was reported in the last 24 hours, he added. Of the new cases reported during the day, five are from Mumbai, two from Pune and one from Kolhapur.
Mumbai's tally now stands at 1012, of which 551 were reported in June and 20 so far in July. Since the start of the year, a total of 2,472 persons have recovered from the infection, the state health department said.
The health department said it has conducted 33,157 COVID-19 tests in Maharashtra since January 1. Since January 1, a total of 41 persons have died of COVID-19, including 40 with comorbidities.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
an hour ago
- News18
If Vaccines Hadn't Saved Us From Covid-19, We Wouldn't Be Here To Question Heart Attacks
Last Updated: There is no conclusive proof that Covid vaccines directly caused a spike in heart attacks but we can't ignore that Covid-19 itself has left behind a legacy of cardiovascular damage The rise in heart-related complications and sudden deaths post-Covid-19 has triggered several debates, especially around the role of vaccines. Social media amplifies claims—often anecdotal, rarely scientific—linking Covid-19 vaccines to cardiac issues. But here's a fundamental question: If these vaccines hadn't been developed in record time, would we have even lived long enough to speculate on their side effects? The latest debate was triggered by a post on the social media platform X, where Karnataka's Chief Minister Siddaramaiah wrote on July 1: 'In the past month alone, in just one district of Hassan, more than twenty people have died due to heart attacks. The government is taking this matter very seriously… It cannot be denied that the hasty approval and distribution of the Covid vaccine to the public could also be a reason for these deaths, as several studies worldwide have recently indicated that COVID vaccines could be a cause for the increasing number of heart attacks…" In response, what we saw throughout last week was a coordinated and deliberate effort from the Centre, leading medical institutions, and vaccine manufacturers to rebuild and reinforce public confidence in Covid-19 vaccines. Siddaramaiah's claim was strongly rebutted, not only by government-run institutions but also by top pharmaceutical executives, researchers, and well-known doctors. Sample this: The Indian Pharmaceutical Alliance (IPA)—the lobby of domestic pharmaceutical companies representing Sun Pharma, Glenmark, Lupin, Cipla and many others—issued a strong statement supporting Covid-19 vaccines. Industry leaders like Kiran Mazumdar-Shaw of Biocon and Samir Mehta of Torrent Pharma also publicly backed vaccine safety and dismissed the unfounded claims. Top doctors from AIIMS and scientists at ICMR have taken to public platforms to bust myths and explain the science, stressing that panic must not replace facts. The Serum Institute of India (SII)—manufacturer of India's poster boy vaccine Covishield—also reaffirmed that Covid-19 vaccines are safe, scientifically validated, and critical in saving lives. Given that over 170 crore doses of Covishield have been administered out of the 200+ crore total vaccine doses in India, this clarification is not just welcome but vital. These clarifications were essential in addressing the growing public anxiety around sudden cardiac deaths, particularly among younger people. While these incidents are tragic and deserve a detailed investigation, the Union government has made it unequivocally clear: these deaths should not be automatically linked to Covid-19 vaccination. Let's understand this scientifically. As of today, there is no conclusive evidence that Covid-19 vaccines directly caused a spike in heart attacks or sudden cardiac arrests in India. However, we must not ignore a crucial truth: Covid-19 itself has left behind a legacy of cardiovascular damage. The virus is known to inflame blood vessels and affect heart muscle tissue. A 2022 study in Nature Medicine found a 63 per cent higher risk of heart attack in patients within a year of Covid infection. Multiple global studies, including those published in respected medical journals such as The Lancet and the New England Journal of Medicine, have shown that the risk of myocarditis and other heart complications is higher after a Covid-19 infection than after vaccination. A study conducted by the Indian Journal of Medical Research—a peer-reviewed publication supported by ICMR—concluded that Covid-19 vaccination was not associated with an increased risk of unexplained sudden death among young adults. On the contrary, the study documented that vaccination reduced the risk of unexplained sudden death in this age group. The Indian Council of Medical Research (ICMR) and the National Technical Advisory Group on Immunisation (NTAGI) have reiterated that adverse events following immunisation (AEFIs) remain extremely rare. India's official AEFI data shows less than 0.01 per cent serious reactions among the more than 2.2 billion doses administered. Add to this another critical factor: Indians are more genetically susceptible to heart diseases than Western populations. According to a Lancet Regional Health Southeast Asia study published in February 2023, the cardiovascular burden in India is higher than the global average. The age-standardised death rate globally is 233 deaths per 1,00,000, while for India it is 282 per 1,00,000. Yet, unfounded narratives continue to gain traction—some fuelled by misinformation, others by genuine grief seeking answers in a complex post-pandemic landscape. What the available evidence shows is that vaccines, by reducing the severity and spread of the virus, likely played a role in limiting long-term cardiovascular consequences. They weren't just about immediate survival—they bought us time and prevented the invisible wave of complications that continues to unfold. Even if science someday finds a small causal link between certain vaccines and rare cardiac events, we must remember: public health is about trade-offs. During a pandemic, decisions must be made under pressure, aiming to save as many lives as possible. Vaccines were not perfect and they were never claimed to be. What they were, and remain, is effective and life-saving on a population scale. It's also essential to acknowledge the wider ecosystem of risk: lockdown-induced sedentary lifestyles, elevated stress, mental health challenges, and delayed chronic care. And also, the genetic structure of Indians, which is vulnerable to metabolic resistance, hence, diabetes and cardiovascular diseases develop relatively easily. These all contribute to rising cardiac cases—and must be part of the conversation. Blaming vaccines alone oversimplifies a deeply layered issue. top videos View all In short, this is not a defence of pharmaceutical companies or vaccine makers who profited heavily during the pandemic, nor is it a dismissal of the real grief of those who lost loved ones. This is a call for nuance. We need to look at the full picture, not just one side of the story. Let's continue investigating, let's strengthen pharmacovigilance and monitoring across India. Remember, we are alive to debate the side effects because the vaccines worked. Get breaking news, in-depth analysis, and expert perspectives on everything from politics to crime and society. Stay informed with the latest India news only on News18. Download the News18 App to stay updated! tags : AIIMS COVID-19 vaccine covishield health matters Kiran Mazumdar-Shaw news18 specials Serum Institute of India Siddaramaiah Location : New Delhi, India, India First Published: July 07, 2025, 10:00 IST News india If Vaccines Hadn't Saved Us From Covid-19, We Wouldn't Be Here To Question Heart Attacks
Hindustan Times
2 hours ago
- Hindustan Times
Covid cases decline in Pune after brief rise in May
After a slight surge in Covid-19 cases in May, Pune city reported a decline in numbers in the month of June, Pune Municipal Corporation (PMC) officials said. However, the situation improved in June, with the number of cases decreasing to 68, they said. (FILE) According to PMC officials, in May, the city reported 93 Covid cases, a significant increase after months of very low activity. However, the situation improved in June, with the number of cases decreasing to 68, they said. Furthermore, from January to April this year, Pune had reported just one COVID-19 case, indicating almost no presence of virus circulation in the city during that period. The rise in May was not serious and was handled well due to ongoing health surveillance and prompt response measures, said the civic health officials. 'The increase in May was minor, and there is no reason for concern at this time. Many cases tested positive in private city hospitals were incorrectly reported to be from the PMC limits. We are continuing our surveillance to ensure early detection and control,' said Dr Vaishali Jadhav, assistant health officer, PMC. PMC authorities have urged citizens to stay alert, maintain hygiene, and consult doctors if they experience symptoms. People should avoid panic and instead focus on being cautious, especially people in high-risk categories. Besides, vaccination, timely testing, and responsible behaviour are still important in keeping COVID-19 under control, they said. As per the statement issued by the Public Health Department, on Sunday Maharashtra reported 8 fresh COVID-19 cases. Of which, 2 are from PMC, 5 are from Mumbai and 1 from Kolhapur. Since January 2025, as many as 2577 covid cases and 41 deaths amongst the infected have been reported. Also, the state has a recovery rate of 95.92%. Besides, since January, as many as 2569 covid cases and 41 deaths amongst the infected have been reported. Furthermore, currently, there are 64 active Covid cases in the state. Since January, Mumbai has reported 1012 covid cases, of which the highest 551 cases were reported in June alone, said Dr Sandeep Sangale, joint director of Health Services. Dr Sangale said the number of cases have declined in the state. 'The team is conducting regular surveillance of influenza-like illness (ILI) and severe acute respiratory syndrome (SARI) patients. Around 5% of ILI patients and all SARI patients are tested for COVID-19. Besides, samples of all positive patients are sent for Whole Genome Sequencing.'
India Gazette
11 hours ago
- India Gazette
Himachal: AIIMS Bilaspur sets target to make state self-reliant in healthcare
Bilaspur (Himachal Pradesh) [India], July 6 (ANI): The All India Institute of Medical Science (AIIMS) Bilaspur is all set to make Himachal Pradesh a self-reliant state in health care. The AIIMS Bilaspur Director, Prof DN Sharma, shared significant milestones of the institute's progress with the media on Sunday, highlighting rapid infrastructure expansion, medical breakthroughs, and a focused drive toward cancer research and trauma care. In just less than three years since its inception, AIIMS Bilaspur has increased its inpatient capacity from 690 to 728 beds, catering to over 1,500 patients daily, with more than 4,000 indoor admissions every month. The institute also recorded its first successful kidney transplant, a major achievement in its clinical journey. Over 30,000 patients are being treated monthly, and the hospital has developed a strong community outreach programme, backed by interdisciplinary collaborations and state-of-the-art equipment, including an MRI facility. AIIMS Bilaspur is equipped with four times more ventilators than other hospitals in Himachal Pradesh, ensuring robust emergency preparedness. With a strong academic backbone, the institute now has 620 students, including 100 MBBS seats, and offers 17 broad specialities. However, Prof. Sharma noted that some faculty positions in medical gastroenterology remain vacant, though recruitment drives are ongoing. Cancer care remains a major focus area, with work underway for a dedicated Trauma Centre, and a proposal for Phase 2 expansion valued at Rs 178.05 crore. A feasibility survey for Rs 332 crore has also been conducted to support future developments, including enhanced cancer treatment infrastructure. AIIMS Bilaspur is also actively participating in ICMR-backed research projects on breast and cervical cancer and has seen high utilisation in its radiation oncology department, treating 83 patients regularly, with daily attendance ranging from 20 to 30 patients, nearing 900 total so far. Prof Sharma emphasised lifestyle-related cancers and rising cases such as lung cancer, along with Delhi topping the chart for prostate cancer prevalence. AIIMS Bilaspur is also expected to soon be equipped with PET scan and titration control facilities to enhance diagnostic precision. AIIMS Bilaspur is now among the fastest-growing AIIMS in the country, both in terms of infrastructure and services and aims to ensure that people in the region no longer need to travel outside Himachal Pradesh for advanced treatment. (ANI)
